Clinical Study on Maintenance Therapy With Selinexor Combined With Azacitidine After Allogeneic Hematopoietic Stem Cell Transplantation for NK/T-cell Lymphoma

NCT07276698 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

39

Enrollment

OTHER

Sponsor class

Conditions

NK T-Cell Lymphoma

Interventions

DRUG: Selinexor, azacitidine

Sponsor

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine